Central Coast coalition aims to launch aerospace economy from Ventura to Santa Cruz
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: Phil Wyatt and his company finally get their due with physics prize
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Teledyne shares hit record after strong earnings report
The acquisition of Flir Systems continues to pay off for Teledyne Technologies, as the Thousand Oaks-based industrial and scientific conglomerate crushed analysts’ expectations in the third quarter and upped its guidance for the full year. Teledyne delivered record sales for the quarter ended Sept. 30, generating $1.3 billion in revenue, a 75.8% increase from the Read More →
Procore announces second recent acquisition
Procore Technologies secured its second acquisition in as many months when the Carpinteria-based construction software company announced on Oct. 22 it had acquired LaborChart. Financial details were not disclosed for this deal, and a timeline of when it would close was also not provided. Procore did say, however, that the acquisition would not have any Read More →
Energy Vault preps to go public, could raise $388M
Westlake Village-based Energy Vault disclosed details of its financial performance for the first time in an Oct. 18 filing with the U.S. Securities and Exchange Commission, filed in advance of its public stock offering and its pending merger with a special purpose acquisition company. Energy Vault, a green energy storage company, agreed to go public Read More →
Amgen’s investment in Neumora marks a return to neuroscience research
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen goes full speed ahead on biosimilar drugs
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
